News

Spero Therapeutics announced that SPR720, an oral agent being developed for the treatment of lung infections caused by NTM, has received QIDP designation from the FDA.

Mycobacterium avium isolates were detected in household water in 81.1% of households sampled in a new study, suggesting a link to Mycobacterium avium complex lung disease.

#ICYMI, here are the highlights from Contagion®'s first-ever TweetChat on Treating Gram-Negative Infections in the Era of Resistance.

Investigators at Memorial Sloan Kettering Cancer Center determined valganciclovir was the preferred first-line preemptive therapy to prevent cytomegalovirus in patients following an allogeneic hematopoietic cell transplantation.

A new assay distinguishes between intact and defective HIV proviruses in infected cells, a study reports.

The length of mechanical friction applied to the needleless connector of a central venous catheter before insertion may make a difference in rate of disinfection.

A study conducted at the Salvador Zubirán National Institute of Health Sciences and Nutrition found that there were no cases of active tuberculosis detected in HSCT patients.

Investigators detected no relevant change in systemic concentrations of 9 probe drugs when rezafungin was dosed concomitantly.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Are we ignoring non-C diff infected rooms and promoting contamination?

The incidence of invasive meningococcal disease fell from 67% in the first quarter of the study period to 4% during the last quarter at a hospital in Spain.

The findings echo the guidelines published by IDSA/SHEA in 2018.

Concerns of at-risk patients forgoing condoms may be driving the reluctance of some clinicians to prescribe the preventive regimen.

A study reports that a respiratory virus infection diagnosis was not linked with a decrease in antibiotic exposure and use of respiratory viral panels did not affect clinical outcomes.

A new study finds that regular use of tenofovir gel helped reduce the risk of genital herpes acquisition in women in sub-Saharan Africa.

Following implementation of stewardship program-guided blood culture communication process, the time to optimal therapy was 9.2 hours shorter for patients at Saint Luke’s Hospital.

Ibuprofen succeeded in fighting S aureus in a laboratory setting, although it’s not clear whether the same effect would hold true in patients with systemic infections.

Rats and other pests pose significant problems for urban areas in the US.

As outpatient medical care becomes more common, are we forgetting the role of infection control?

Antibiotic prescription following ventilation in children with RSV-LRTI was associated with a 1.21-day shorter duration of ventilation and a 2.07-day shorter length of hospital stay.

Hospital-onset sepsis is twice as deadly as community-onset sepsis and increases the risk of death 3-fold, according to the results of a cohort study comprising 2.3 million adult patients.

The FDA has accepted New Drug Applications for oral and IV formulations of Nabriva Therapeutics’ lefamulin for the treatment of community-acquired bacterial pneumonia.

The FDA has approved room temperature stable, premixed vancomycin injections, which will be available in ready-to-use bags.

Although IV antibiotics have been the standard of care for bone and joint infections, a new study finds that oral antibiotics were non-inferior.

A new study reports that many health care workers had the ability to neutralize the Ebola virus, despite never exhibiting symptoms of infection.

A computer simulation model developed by NYU investigators uses math to forecast influenza activity.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.